Results 261 to 270 of about 789,882 (293)

Dynamic versus static biomarkers in cancer immune checkpoint blockade: unravelling complexity

Nature Reviews Drug Discovery, 2017
Willem J Lesterhuis, Anthony Bosco, Michael Small   +2 more
exaly  

Revisiting checkpoint blockade

Nature Biotechnology, 2022
openaire   +2 more sources

De Novo Epigenetic Programs Inhibit PD-1 Blockade-Mediated T Cell Rejuvenation

Cell, 2017
Hazem E Ghoneim, Yiping Fan, Ardiana Moustaki   +2 more
exaly  

LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade

Cell, 2018
Wanqiang Sheng, Daniel D De Carvalho, Thao H Nguyen   +2 more
exaly  

Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade

Cell, 2018
Sachet A Shukla, Pavan Bachireddy, Bastian Schilling   +2 more
exaly  

Angiotensin II Blockade

New England Journal of Medicine, 1977
R E, Keenan, M L, Horne, V M, Conklin
openaire   +2 more sources

Non-conventional Inhibitory CD4+Foxp3−PD-1hi T Cells as a Biomarker of Immune Checkpoint Blockade Activity

Cancer Cell, 2018
Roberta Zappasodi, Sadna Budhu, Matthew D Hellmann   +2 more
exaly  

Blockade

International Affairs, 1932
openaire   +1 more source

Between blockade and counter-blockade

1941
openaire   +1 more source

PD-1–PD-L1 immune-checkpoint blockade in B-cell lymphomas

Nature Reviews Clinical Oncology, 2016
Razelle Kurzrock
exaly